The Survival Rate Among Unvaccinated, First Dose, and Second Dose Brazilian Hospitalized and ICU COVID Patients by Age Group
Resumo
Brazil has a nationwide surveillance repository of severe acute respiratory disease for hospitalized patients. This repository has stored data for 1,177,151 hospitalized and ICU COVID-19 patients in 2021. In order to statistically validate the difference in the survival rate among unvaccinated, one dose, and two doses, we preprocess the data, divide it into age groups and between hospitalized and ICU patients. This work presents statistical evidence for hospitalized patients that lethality increase with age and decreases with vaccines, especially with the second dose. We found a significant difference among age groups and between hospitalized and ICU, indicating the need to separate these groups when analyzing lethality and comorbidities.
Referências
Fiocruz (2021a). O tempo dos dados: explorando a cobertura e oportunidade do sivep-gripe e o e-sus ve. [link], Last accessed on 2022-02-23.
Fiocruz (2021b). Um balanço da pandemia em 2021 em um cenário de incertezas e falta de dados. [link], Last accessed on 2022-02-23.
Globo (2020). Entenda como é feita a coleta de dados da covid-19 em todo o país. [link], Last accessed on 2022-02-23.
Marinho, M. F. (2021). Semelhanças e diferenças na interpretação dos dados sobre sg, srag e covid-19: Sim, sivep-gripe e cartórios de registro civil. Planejamento e Gestão Volume 2, page 112.
Oliveira, E. A., Colosimo, E. A., e Silva, A. C. S., Mak, R. H., Martelli, D. B., Silva, L. R., Martelli-Júnior, H., and Oliveira, M. C. L. (2021). Clinical characteristics and risk factors for death among hospitalised children and adolescents with covid-19 in brazil: an analysis of a nationwide database. The Lancet Child & Adolescent Health, 5(8):559-568.
OpenDataSUS (2022). Banco de dados de síndrome respiratória aguda grave. https://opendatasus.saude.gov.br/dataset/srag-2021-e-2022, Last accessed on 2022-02-23.
Silva, G. A., Jardim, B. C., and Lotufo, P. A. (2021). Mortalidade por covid-19 padronizada por idade nas capitais das diferentes regiões do brasil. Cadernos de Saúde Pública, 37:e00039221.
Whitaker, H. J., Tsang, R. S., Byford, R., Andrews, N. J., Sherlock, J., Pillai, P. S., Williams, J., Button, E., Campbell, H., Sinnathamby, M., et al. (2022). Pfizer-biontech and oxford astrazeneca covid-19 vaccine effectiveness and immune response among individuals in clinical risk groups. Journal of Infection.